NASCAR announced that it is teaming up with Janssen Pharmaceuticals, Inc., to help make a difference for racing fans who are at risk for or are living with blood clots. Janssen, the maker of XARELTO (rivaroxaban), an important medicine used to treat and help prevent blood clots, is now the Official Cardiovascular Partner of NASCAR. Blood clots have hit close to home for the NASCAR community. Brian Vickers, full-time driver of the #55 Aaron’s Dream Machine Toyota for Michael Waltrip Racing in the NASCAR Sprint Cup Series, recently overcame his second episode with the condition. Having completed his treatment with XARELTO and being cleared by his physician, Brian is now competing again in the NASCAR Sprint Cup Series and is currently 18th in points. 900,000 Americans experience blood clots every year2 that result in nearly 300,000 deaths. According to The National Blood Clot Alliance, many factors can increase a person’s risk for developing blood clots, including age; being overweight; having other chronic diseases; immobility; hormones and pregnancy; long air travel; surgery; trauma or injury.(NASCAR)(3-22-2014)
